- Home
- TMDX vs SLGN Comparison
TMDX vs SLGN Comparison
Compare TMDX & SLGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TMDX
- SLGN
- Stock Information
- Founded
- TMDX 1998
- SLGN 1987
- Country
- TMDX United States
- SLGN United States
- Employees
- TMDX N/A
- SLGN N/A
- Industry
- TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- SLGN Containers/Packaging
- Sector
- TMDX Health Care
- SLGN Industrials
- Exchange
- TMDX Nasdaq
- SLGN Nasdaq
- Market Cap
- TMDX 4.0B
- SLGN 4.6B
- IPO Year
- TMDX 2019
- SLGN 1997
- Fundamental
- Price
- TMDX $130.67
- SLGN $44.46
- Analyst Decision
- TMDX Buy
- SLGN Strong Buy
- Analyst Count
- TMDX 12
- SLGN 9
- Target Price
- TMDX $128.92
- SLGN $60.11
- AVG Volume (30 Days)
- TMDX 868.2K
- SLGN 1.0M
- Earning Date
- TMDX 10-29-2025
- SLGN 10-29-2025
- Dividend Yield
- TMDX N/A
- SLGN 1.79%
- EPS Growth
- TMDX 2163.11
- SLGN N/A
- EPS
- TMDX 2.02
- SLGN 2.81
- Revenue
- TMDX $531,292,000.00
- SLGN $6,162,113,000.00
- Revenue This Year
- TMDX $38.78
- SLGN $11.86
- Revenue Next Year
- TMDX $20.76
- SLGN $2.75
- P/E Ratio
- TMDX $64.68
- SLGN $15.87
- Revenue Growth
- TMDX 48.09
- SLGN 5.49
- 52 Week Low
- TMDX $55.00
- SLGN $41.30
- 52 Week High
- TMDX $145.50
- SLGN $58.14
- Technical
- Relative Strength Index (RSI)
- TMDX 69.28
- SLGN 56.43
- Support Level
- TMDX $108.34
- SLGN $44.13
- Resistance Level
- TMDX $118.51
- SLGN $45.17
- Average True Range (ATR)
- TMDX 6.15
- SLGN 0.90
- MACD
- TMDX 1.78
- SLGN 0.34
- Stochastic Oscillator
- TMDX 86.45
- SLGN 78.59
About TMDX TransMedics Group Inc.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
About SLGN Silgan Holdings Inc.
Silgan Holdings manufactures about half of the metal food containers in North America. Its major customers include Campbell Soup, Nestle, and Del Monte. Silgan's other business segments include plastic dispensers and containers for personal and healthcare products and a closures business that manufactures metal and plastic lids and caps.